2025-08-25
Australia's aesthetic market is entering a high-growth phase, with nearly 7 million adults considering cosmetic surgery and industry value projected at US$1.5 billion in 2024. Strong demand for injectables and advanced devices, supported by new national standards, offers aesthetic medical device manufacturers strong potential to introduce innovative solutions and capture growth in this dynamic market.
more
2025-08-25
On July 21, 2025, Qualtech hosted a webinar featuring Mobius Medical's Co-Founder and Clinical Director, Stefan Czyniewski, on "Accelerating Innovation: Why Australia Is the Ideal Partner for Your Next Clinical Trial". The session emphasized Australia’s speed and cost-efficiency under the Clinical Trial Notification (CTN) scheme, world-class infrastructure, and broad international acceptance of trial data. Key comparisons with the United States highlighted faster start-up timelines, simpler regulatory pathways, and substantial financial incentives such as the R&D Tax Rebate. With its favorable environment for early-phase medical device and diagnostic studies, Australia stands out as a strategic launchpad for global clinical development.
more
2025-08-25
The NMPA has released new measures to foster innovation and strengthen regulation of high-end medical devices such as surgical robots, advanced imaging systems, AI medical devices, and innovative biomaterials. The policy emphasizes faster review pathways, improved standards, stronger lifecycle oversight, and enhanced international collaboration, aiming to accelerate market access and boost the global competitiveness of China's medical device industry.
more
 CMEH 2025 Banner - 202509.png?v=1757652623)
